Emory University Incyte Corp Transaction History

Emory University

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $2.09 Million - $2.48 Million	-28,714 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $14,409 - $17,385	196 Added 0.69%	28,714 $2.44 Million
Q1 2019 May 09, 2019	SELL	$63.56 - $88.17 $454,644 - $630,680	-7,153 Reduced 20.05%	28,518 $2.45 Million
Q4 2018 Feb 12, 2019	BUY	$58.5 - $69.94 $2.09 Million - $2.49 Million	35,671 New	35,671 $2.27 Million

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

Stay updated on Emory University with notifications on news.